Abnormal Striatal Dopamine Transmission in Schizophrenia

By Brunelin Jerome   Fecteau Shirley   Suaud-Chagny Marie-Francoise  

Current Medicinal Chemistry, Vol. 20, Iss. 3, 2013-01 ,pp. : 397-404

Bentham Science Publishers

Access to resources Recommend Favorite

Absence of detectable striatal dopamine D 4 receptors in drug-treated schizophrenia

By Reynolds G.P.   Mason S.L.  

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

Abnormal mesolimbic dopamine function following neonatal hippocampal damage: implications for schizophrenia

By Lipska B.K.   Lillrank S.M.   Wood G.K.   Weinberger D.R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 230-230

Elsevier

Access to resources Recommend Favorite

Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D₂ receptor occupancy in patients with schizophrenia

By Arakawa Ryosuke   Ito Hiroshi   Takano Akihiro   Takahashi Hidehiko   Morimoto Takuya   Sassa Takeshi   Ohta Katsuya   Kato Motoichiro   Okubo Yoshiro   Suhara Tetsuya  

Psychopharmacology, Vol. 197, Iss. 2, 2008-04 ,pp. : 229-235

Springer Publishing Company

Access to resources Recommend Favorite

Effects of some antioxidative aporphine derivatives on striatal dopaminergic transmission and on MPTP-induced striatal dopamine depletion in B6CBA mice

By Loghin F.   Chagraoui A.   Asencio M.   Comoy E.   Speisky H.   Cassels B.K.   Protais P.  

European Journal of Pharmaceutical Sciences, Vol. 18, Iss. 2, 2003-02 ,pp. : 133-140

Elsevier

Access to resources Recommend Favorite